Dr. Andrea Traube is CEO of KyooBe Tech GmbH, a subsidiary of the Bausch + Ströbel Group, that develops and offers innovative platform technologies for ATMP production and pathogen inactivation. For over twenty years, she has been involved in various roles in implementing automation and production concepts, with a focus on cell culture processes and the production of cell and gene therapies.